Rapid Assessment of Biomarkers on Single Extracellular Vesicles Using ‘Catch and Display’ on Ultrathin Nanoporous Silicon Nitride Membranes

Samuel N. Walker,Kilean Lucas,Marley J. Dewey,Stephen Badylak,George Hussey,Jonathan Flax,James L. McGrath

DOI: https://doi.org/10.1101/2024.04.29.589900

2024-05-02

Abstract:Extracellular vesicles (EVs) are particles secreted by all cells that carry bioactive cargo and facilitate intercellular communication with roles in normal physiology and disease pathogenesis. EVs have tremendous diagnostic and therapeutic potential and accordingly, the EV field has grown exponentially in recent years. Bulk assays lack the sensitivity to detect rare EV subsets relevant to disease, and while single EV analysis techniques remedy this, they are undermined by complicated detection schemes often coupled with prohibitive instrumentation. To address these issues, we propose a microfluidic technique for EV characterization called ‘ tch and isplay for iquid iopsy (CAD-LB)’. CAD-LB rapidly captures fluorescently labeled EVs in the similarly-sized pores of an ultrathin silicon nitride membrane. Minimally processed sample is introduced pipette injection into a simple microfluidic device which is directly imaged using fluorescence microscopy for a rapid assessment of EV number and biomarker colocalization. In this work, nanoparticles were first used to define the accuracy and dynamic range for counting and colocalization by CAD-LB. Following this, the same assessments were made for purified EVs and for unpurified EVs in plasma. Biomarker detection was validated using CD9 in which Western blot analysis confirmed that CAD-LB faithfully recapitulated differing expression levels among samples. We further verified that CAD-LB captured the known increase in EV-associated ICAM-1 following the cytokine stimulation of endothelial cells. Finally, to demonstrate CAD-LB’s clinical potential, we show that EV biomarkers indicative of immunotherapy responsiveness are successfully detected in the plasma of bladder cancer patients undergoing immune checkpoint blockade.

Bioengineering

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to improve the efficiency, accuracy and applicability of single - analysis techniques for extracellular vesicles (EVs). Specifically, the paper proposes a microfluidic technique named "Catch and Display for Liquid Biopsy (CAD - LB)", aiming to quickly capture and display fluorescently - labeled EVs, and to evaluate the EV quantity and biomarker co - localization situation through direct imaging with a fluorescence microscope. This technique aims to overcome the complex detection schemes and high instrument cost problems in existing single - EV analysis techniques, while providing higher sensitivity and dynamic range, and is suitable for clinical diagnosis settings.

The key points of the paper include:
1. **Technical principle**: CAD - LB uses an ultrathin nanoporous silicon nitride membrane to capture particles similar in size to the target EVs. This membrane has extremely high permeability and optical transparency, and can effectively capture single EVs while allowing protein and antibody molecules to pass through.
2. **Experimental verification**: Through experiments using fluorescent nanoparticles and purified EVs, the accuracy and dynamic range of CAD - LB in counting and co - localization detection were verified. The results show that CAD - LB exhibits a highly linear response in the concentration range as low as 10 ^ 2 to as high as 10 ^ 6, and can still maintain high accuracy in high - density situations.
3. **Clinical application potential**: The paper further demonstrates the clinical potential of CAD - LB in detecting EV biomarkers related to the immunotherapy response of bladder cancer patients, proving the feasibility and effectiveness of this technique in practical applications.

In conclusion, through the development of the CAD - LB technique, this paper aims to provide a simple, fast, accurate and cost - effective method for single - EV analysis, thereby promoting the application of EVs in disease diagnosis and treatment.